[
  {
    "ts": "2026-01-05T03:21:14+00:00",
    "headline": "Venezuelan Oil Faces Long Road to Lasting Recovery, Analysts Say",
    "summary": "Venezuela could raise production to 2.5 million barrels per day over the next decade, up from the current level of 0.8 million, according to analysts at JPMorgan Chase & Co. In the short term, it’s unclear how much oil Venezuela will be able to export due to the political transition and whether flows to China will continue.  And while President Donald Trump has said US companies will spend billions of dollars to rebuild the country’s energy infrastructure over the longer term, there are big doubts about whether the oil majors will want to invest in what is a very uncertain environment.",
    "url": "https://finance.yahoo.com/news/venezuelan-oil-faces-long-road-032114500.html",
    "source": "Bloomberg",
    "provider": "yfinance",
    "raw": {
      "id": "a646cb6b-f1b1-3ada-93f6-0e8fdf4e8f23",
      "content": {
        "id": "a646cb6b-f1b1-3ada-93f6-0e8fdf4e8f23",
        "contentType": "STORY",
        "title": "Venezuelan Oil Faces Long Road to Lasting Recovery, Analysts Say",
        "description": "",
        "summary": "Venezuela could raise production to 2.5 million barrels per day over the next decade, up from the current level of 0.8 million, according to analysts at JPMorgan Chase & Co. In the short term, it’s unclear how much oil Venezuela will be able to export due to the political transition and whether flows to China will continue.  And while President Donald Trump has said US companies will spend billions of dollars to rebuild the country’s energy infrastructure over the longer term, there are big doubts about whether the oil majors will want to invest in what is a very uncertain environment.",
        "pubDate": "2026-01-05T03:21:14Z",
        "displayTime": "2026-01-05T03:21:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/bloomberg_holding_pen_162/1308d78ac2591e9aaa8606d7d505fd0e",
          "originalWidth": 2000,
          "originalHeight": 1331,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uGph689bHCeFTtr1LMCipg--~B/aD0xMzMxO3c9MjAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/bloomberg_holding_pen_162/1308d78ac2591e9aaa8606d7d505fd0e.cf.webp",
              "width": 2000,
              "height": 1331,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Mo3xwVWqsaH9ASlMQWSg7A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/bloomberg_holding_pen_162/1308d78ac2591e9aaa8606d7d505fd0e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Bloomberg",
          "url": "https://www.bloomberg.com/company"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/venezuelan-oil-faces-long-road-032114500.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/venezuelan-oil-faces-long-road-032114500.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "CL=F"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T08:45:02+00:00",
    "headline": "Investors Expect the Market to Keep Rallying This Year",
    "summary": "3.7% That's how much Bank of America expects the S&P 500 to increase in 2026. JPMorgan Chase and Goldman Sachs expect the index to rise more. Should the S&P 500 climb for a fourth consecutive year, it would be the longest such streak since 2007.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-05-2026/card/investors-expect-the-market-to-keep-rallying-this-year-zAZ7n01V92ZPWrMwgrjL?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "9aa204e1-32f3-3a24-a147-a1fdf43e05da",
      "content": {
        "id": "9aa204e1-32f3-3a24-a147-a1fdf43e05da",
        "contentType": "STORY",
        "title": "Investors Expect the Market to Keep Rallying This Year",
        "description": "",
        "summary": "3.7% That's how much Bank of America expects the S&P 500 to increase in 2026. JPMorgan Chase and Goldman Sachs expect the index to rise more. Should the S&P 500 climb for a fourth consecutive year, it would be the longest such streak since 2007.",
        "pubDate": "2026-01-05T08:45:02Z",
        "displayTime": "2026-01-05T08:45:02Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/9aa204e1-32f3-3a24-a147-a1fdf43e05da/investors-expect-the-market.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
          "originalWidth": 1200,
          "originalHeight": 630,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AC.ajdS9OghfMNW3mzlvpg--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 1200,
              "height": 630,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J5JxVR9DmLuomtxdXBS7Uw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-05-2026/card/investors-expect-the-market-to-keep-rallying-this-year-zAZ7n01V92ZPWrMwgrjL?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "BAC"
            },
            {
              "symbol": "GS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T11:00:00+00:00",
    "headline": "IDEAYA Biosciences Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the 44th Annual J.P. Morgan Healthcare Conference.",
    "url": "https://finance.yahoo.com/news/ideaya-biosciences-announces-participation-44th-110000193.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "f22327a1-0951-3f95-bb88-4a00cc4358f7",
      "content": {
        "id": "f22327a1-0951-3f95-bb88-4a00cc4358f7",
        "contentType": "STORY",
        "title": "IDEAYA Biosciences Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the 44th Annual J.P. Morgan Healthcare Conference.",
        "pubDate": "2026-01-05T11:00:00Z",
        "displayTime": "2026-01-05T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/74efd2e2f7cc28d3a6ce5efb40fb6e7d",
          "originalWidth": 400,
          "originalHeight": 263,
          "caption": "(PRNewsfoto/IDEAYA Biosciences, Inc.)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ys1P59VsmJC82_UFYSirrw--~B/aD0yNjM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/74efd2e2f7cc28d3a6ce5efb40fb6e7d.cf.webp",
              "width": 400,
              "height": 263,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZgYI.dEk9PGbPMvsgTfH.A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/74efd2e2f7cc28d3a6ce5efb40fb6e7d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ideaya-biosciences-announces-participation-44th-110000193.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ideaya-biosciences-announces-participation-44th-110000193.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IDYA"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T12:30:00+00:00",
    "headline": "Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "NORWOOD, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present a corporate overview at the 2026 Annual J.P. Morgan Healthcare Conference, to be held January 12-15, 2026, in San Francisco, CA. 44th Annual J.P. Morgan Healthcare Conference Format: Presentation and one-on-one investor meetings Date: January 15, 202",
    "url": "https://finance.yahoo.com/news/corbus-pharmaceuticals-present-44th-annual-123000833.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "df7256e8-9d02-3f27-be46-6dcd7912a307",
      "content": {
        "id": "df7256e8-9d02-3f27-be46-6dcd7912a307",
        "contentType": "STORY",
        "title": "Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "NORWOOD, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present a corporate overview at the 2026 Annual J.P. Morgan Healthcare Conference, to be held January 12-15, 2026, in San Francisco, CA. 44th Annual J.P. Morgan Healthcare Conference Format: Presentation and one-on-one investor meetings Date: January 15, 202",
        "pubDate": "2026-01-05T12:30:00Z",
        "displayTime": "2026-01-05T12:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/1cfd910a0fd0d9bb85aa1f8b04be8843",
          "originalWidth": 320,
          "originalHeight": 180,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6dyqeOodY.jwQhgB05.dPg--~B/aD0xODA7dz0zMjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/1cfd910a0fd0d9bb85aa1f8b04be8843.cf.webp",
              "width": 320,
              "height": 180,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zMKliV.8B.c5SEEDKwHGJg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/1cfd910a0fd0d9bb85aa1f8b04be8843.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/corbus-pharmaceuticals-present-44th-annual-123000833.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/corbus-pharmaceuticals-present-44th-annual-123000833.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRBP"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T12:30:00+00:00",
    "headline": "Neurogene to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "NEW YORK, January 05, 2026--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that Company management will participate in the 44th Annual J.P. Morgan Healthcare Conference.",
    "url": "https://finance.yahoo.com/news/neurogene-participate-44th-annual-j-123000849.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "ad287fdf-edaa-3746-90bb-f4eaf4bb5b7f",
      "content": {
        "id": "ad287fdf-edaa-3746-90bb-f4eaf4bb5b7f",
        "contentType": "STORY",
        "title": "Neurogene to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "NEW YORK, January 05, 2026--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that Company management will participate in the 44th Annual J.P. Morgan Healthcare Conference.",
        "pubDate": "2026-01-05T12:30:00Z",
        "displayTime": "2026-01-05T12:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/neurogene-participate-44th-annual-j-123000849.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/neurogene-participate-44th-annual-j-123000849.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "NGNE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T12:05:00+00:00",
    "headline": "NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "FORT MYERS, Fla., January 05, 2026--NeoGenomics will participate in the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco.",
    "url": "https://finance.yahoo.com/news/neogenomics-participate-44th-annual-j-120500551.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "024be5d6-ae4e-312c-b5c2-2235dcb9262b",
      "content": {
        "id": "024be5d6-ae4e-312c-b5c2-2235dcb9262b",
        "contentType": "STORY",
        "title": "NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "FORT MYERS, Fla., January 05, 2026--NeoGenomics will participate in the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco.",
        "pubDate": "2026-01-05T12:05:00Z",
        "displayTime": "2026-01-05T12:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/36d921674d0234781f8df458e1441550",
          "originalWidth": 2390,
          "originalHeight": 984,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CTAZxqpEy_BBXarHFlEMZQ--~B/aD05ODQ7dz0yMzkwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/36d921674d0234781f8df458e1441550.cf.webp",
              "width": 2390,
              "height": 984,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QfDwodCIB7GUls_j9fAvTg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/36d921674d0234781f8df458e1441550.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/neogenomics-participate-44th-annual-j-120500551.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/neogenomics-participate-44th-annual-j-120500551.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NEO"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T12:00:00+00:00",
    "headline": "Nanoscope Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to retinal degeneration, announced today that Sulagna Bhattacharya, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12th, 2026 from 11:30 to 11:55 AM PST.",
    "url": "https://finance.yahoo.com/news/nanoscope-therapeutics-present-44th-annual-120000830.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "60c89d6f-1038-35ed-8e32-4ac2fac82d99",
      "content": {
        "id": "60c89d6f-1038-35ed-8e32-4ac2fac82d99",
        "contentType": "STORY",
        "title": "Nanoscope Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to retinal degeneration, announced today that Sulagna Bhattacharya, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12th, 2026 from 11:30 to 11:55 AM PST.",
        "pubDate": "2026-01-05T12:00:00Z",
        "displayTime": "2026-01-05T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/c7763a47ce9d084fd0a8fbf1bc78300d",
          "originalWidth": 400,
          "originalHeight": 81,
          "caption": "Nanoscope Therapeutics Logo (PRNewsfoto/Nanoscope Therapeutics)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JASJfCKg_yK6LIQt9i0CGA--~B/aD04MTt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/c7763a47ce9d084fd0a8fbf1bc78300d.cf.webp",
              "width": 400,
              "height": 81,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L6Rz7kq8unySZrJsFRHe9g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c7763a47ce9d084fd0a8fbf1bc78300d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nanoscope-therapeutics-present-44th-annual-120000830.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nanoscope-therapeutics-present-44th-annual-120000830.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T12:00:00+00:00",
    "headline": "Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026",
    "summary": "CAMBRIDGE, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that its management team is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 8:15 a.m. PST / 11:15 a.m. EST. The live webcast will be accessible on the Investors section of the company's website (www.agios.c",
    "url": "https://finance.yahoo.com/news/agios-present-44th-annual-j-120000679.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "3bf58afd-ab06-36f9-9a76-38f77efbca87",
      "content": {
        "id": "3bf58afd-ab06-36f9-9a76-38f77efbca87",
        "contentType": "STORY",
        "title": "Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026",
        "description": "",
        "summary": "CAMBRIDGE, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that its management team is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 8:15 a.m. PST / 11:15 a.m. EST. The live webcast will be accessible on the Investors section of the company's website (www.agios.c",
        "pubDate": "2026-01-05T12:00:00Z",
        "displayTime": "2026-01-05T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/c805cec60d1b895ac7995fe9db60d850",
          "originalWidth": 7506,
          "originalHeight": 1341,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wh41sLdHAukxtTC9KU7row--~B/aD0xMzQxO3c9NzUwNjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/c805cec60d1b895ac7995fe9db60d850.cf.webp",
              "width": 7506,
              "height": 1341,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/W4rPJZ.iz02a7GwWOSlNKw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c805cec60d1b895ac7995fe9db60d850.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/agios-present-44th-annual-j-120000679.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/agios-present-44th-annual-j-120000679.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AGIO"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T12:00:00+00:00",
    "headline": "United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "SILVER SPRING, Md. & DURHAM, N.C., January 05, 2026--United Therapeutics Corporation (Nasdaq: UTHR) announced today that Dr. Martine Rothblatt, Chairperson and Chief Executive Officer, will present a company overview and update on Monday, January 12, 2026, from 1:30 to 2:10 p.m. PST, at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco.",
    "url": "https://finance.yahoo.com/news/united-therapeutics-corporation-present-44th-120000917.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "2b398c9b-9d1e-3388-a617-19942d70bd38",
      "content": {
        "id": "2b398c9b-9d1e-3388-a617-19942d70bd38",
        "contentType": "STORY",
        "title": "United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "SILVER SPRING, Md. & DURHAM, N.C., January 05, 2026--United Therapeutics Corporation (Nasdaq: UTHR) announced today that Dr. Martine Rothblatt, Chairperson and Chief Executive Officer, will present a company overview and update on Monday, January 12, 2026, from 1:30 to 2:10 p.m. PST, at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco.",
        "pubDate": "2026-01-05T12:00:00Z",
        "displayTime": "2026-01-05T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/united-therapeutics-corporation-present-44th-120000917.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/united-therapeutics-corporation-present-44th-120000917.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "UTHR"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T12:00:00+00:00",
    "headline": "Seaport Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "BOSTON, January 05, 2026--Seaport Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference.",
    "url": "https://finance.yahoo.com/news/seaport-therapeutics-present-44th-annual-120000718.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "16284af8-2fad-3188-8d7e-fbb832363094",
      "content": {
        "id": "16284af8-2fad-3188-8d7e-fbb832363094",
        "contentType": "STORY",
        "title": "Seaport Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "BOSTON, January 05, 2026--Seaport Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference.",
        "pubDate": "2026-01-05T12:00:00Z",
        "displayTime": "2026-01-05T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/094ecbb1d9041330692782bed7f54187",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/06o_41RCEb0bOJr1paWpeQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/094ecbb1d9041330692782bed7f54187.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FSh3VZGiJFMD6AdtJtDjQw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/094ecbb1d9041330692782bed7f54187.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/seaport-therapeutics-present-44th-annual-120000718.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/seaport-therapeutics-present-44th-annual-120000718.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T12:00:00+00:00",
    "headline": "Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "CRANBURY, N.J., January 05, 2026--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that the Company will participate in the 44th Annual J.P. Morgan Healthcare Conference, in San Francisco. Gaurav Shah, M.D., Chief Executive Officer, is scheduled to present on Wednesday, January 14, at 11:15 a.m. PT and host investor meetings throughout th",
    "url": "https://finance.yahoo.com/news/rocket-pharmaceuticals-participate-44th-annual-120000360.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "94abc177-d7ec-3d73-a230-6ec2436f6123",
      "content": {
        "id": "94abc177-d7ec-3d73-a230-6ec2436f6123",
        "contentType": "STORY",
        "title": "Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "CRANBURY, N.J., January 05, 2026--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that the Company will participate in the 44th Annual J.P. Morgan Healthcare Conference, in San Francisco. Gaurav Shah, M.D., Chief Executive Officer, is scheduled to present on Wednesday, January 14, at 11:15 a.m. PT and host investor meetings throughout th",
        "pubDate": "2026-01-05T12:00:00Z",
        "displayTime": "2026-01-05T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/8f06155d12f2080b8605335d57744de6",
          "originalWidth": 1200,
          "originalHeight": 465,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nhqC2JwhnsrwqVsW1O_TNQ--~B/aD00NjU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/8f06155d12f2080b8605335d57744de6.cf.webp",
              "width": 1200,
              "height": 465,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/goF6rWeXp7m64CLHuL_bxw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/8f06155d12f2080b8605335d57744de6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/rocket-pharmaceuticals-participate-44th-annual-120000360.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/rocket-pharmaceuticals-participate-44th-annual-120000360.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RCKT"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T12:00:00+00:00",
    "headline": "Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "WATERTOWN, Mass., January 05, 2026--Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs with an emphasis on treatments for viral infections and immunological diseases, today announced that Jay R. Luly, Ph.D., Enanta’s President and Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 3:00 p.m. PT in San Francisco, CA.",
    "url": "https://finance.yahoo.com/news/enanta-pharmaceuticals-present-44th-annual-120000533.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "2e0dcc53-1dad-3929-94cd-689cde2979b0",
      "content": {
        "id": "2e0dcc53-1dad-3929-94cd-689cde2979b0",
        "contentType": "STORY",
        "title": "Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "WATERTOWN, Mass., January 05, 2026--Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs with an emphasis on treatments for viral infections and immunological diseases, today announced that Jay R. Luly, Ph.D., Enanta’s President and Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 3:00 p.m. PT in San Francisco, CA.",
        "pubDate": "2026-01-05T12:00:00Z",
        "displayTime": "2026-01-05T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/288bd4cbb978b4dcc3f7dc3e1a982ac4",
          "originalWidth": 2190,
          "originalHeight": 732,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w1s.Ramw8Q7IODeKifklLw--~B/aD03MzI7dz0yMTkwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/288bd4cbb978b4dcc3f7dc3e1a982ac4.cf.webp",
              "width": 2190,
              "height": 732,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pnQKwSJOcehjKUN.2otCOQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/288bd4cbb978b4dcc3f7dc3e1a982ac4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/enanta-pharmaceuticals-present-44th-annual-120000533.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/enanta-pharmaceuticals-present-44th-annual-120000533.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ENTA"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T12:00:00+00:00",
    "headline": "Cellarity to Present at 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "SOMERVILLE, Mass., January 05, 2026--Cellarity CEO Ted Myles will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 10:00 a.m. PST.",
    "url": "https://finance.yahoo.com/news/cellarity-present-44th-annual-j-120000561.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "c724cc1e-add2-331c-927e-8bd9fb90f47d",
      "content": {
        "id": "c724cc1e-add2-331c-927e-8bd9fb90f47d",
        "contentType": "STORY",
        "title": "Cellarity to Present at 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "SOMERVILLE, Mass., January 05, 2026--Cellarity CEO Ted Myles will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 10:00 a.m. PST.",
        "pubDate": "2026-01-05T12:00:00Z",
        "displayTime": "2026-01-05T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/326b7de8a6ff75f8cd0ce1be74438571",
          "originalWidth": 2062,
          "originalHeight": 440,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Sl7o9zf2HBsSNYFTUI48MA--~B/aD00NDA7dz0yMDYyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/326b7de8a6ff75f8cd0ce1be74438571.cf.webp",
              "width": 2062,
              "height": 440,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_gHd46lgZGmfFSQQMQSIqA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/326b7de8a6ff75f8cd0ce1be74438571.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cellarity-present-44th-annual-j-120000561.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cellarity-present-44th-annual-j-120000561.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T12:00:00+00:00",
    "headline": "Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 in patients with IgA nephropathy expected to begin mid-2026; preliminary data anticipated in 2027JADE201, a half-life extended afucosylated anti-BAFF receptor antibody, expected to advance into first-in-human study in rheumatoid arthritis patients in the second quarter of 2026; interim data anticipated in 2027Third development candidate, JADE301, nomin",
    "url": "https://finance.yahoo.com/news/jade-biosciences-outlines-key-2026-120000719.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "a411f49e-a019-3398-a09b-e08d5e33e48a",
      "content": {
        "id": "a411f49e-a019-3398-a09b-e08d5e33e48a",
        "contentType": "STORY",
        "title": "Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 in patients with IgA nephropathy expected to begin mid-2026; preliminary data anticipated in 2027JADE201, a half-life extended afucosylated anti-BAFF receptor antibody, expected to advance into first-in-human study in rheumatoid arthritis patients in the second quarter of 2026; interim data anticipated in 2027Third development candidate, JADE301, nomin",
        "pubDate": "2026-01-05T12:00:00Z",
        "displayTime": "2026-01-05T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/f3664c45928c46deca5f70bd7fefe5be",
          "originalWidth": 1800,
          "originalHeight": 672,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G0x7QDRe6AWs4eEcWcsuaQ--~B/aD02NzI7dz0xODAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/f3664c45928c46deca5f70bd7fefe5be.cf.webp",
              "width": 1800,
              "height": 672,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ggV8vlwmV30LDqglUx4tow--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/f3664c45928c46deca5f70bd7fefe5be.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jade-biosciences-outlines-key-2026-120000719.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jade-biosciences-outlines-key-2026-120000719.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "JBIO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T12:00:00+00:00",
    "headline": "Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "WALTHAM, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13th, 2026 at 9:45 a.m. PT/1",
    "url": "https://finance.yahoo.com/news/sionna-therapeutics-present-44th-annual-120000800.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "52712e43-0e8a-3fb4-8f6f-55294de7cfee",
      "content": {
        "id": "52712e43-0e8a-3fb4-8f6f-55294de7cfee",
        "contentType": "STORY",
        "title": "Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "WALTHAM, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13th, 2026 at 9:45 a.m. PT/1",
        "pubDate": "2026-01-05T12:00:00Z",
        "displayTime": "2026-01-05T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/faa71dd2d77db0091b76f767e953b54b",
          "originalWidth": 300,
          "originalHeight": 300,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sBROPuNMlG0BVrGTPQKQKA--~B/aD0zMDA7dz0zMDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/faa71dd2d77db0091b76f767e953b54b.cf.webp",
              "width": 300,
              "height": 300,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/x.nR999SRMAEpdOKygo0mQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/faa71dd2d77db0091b76f767e953b54b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sionna-therapeutics-present-44th-annual-120000800.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sionna-therapeutics-present-44th-annual-120000800.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SION"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T12:00:00+00:00",
    "headline": "Apellis Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "WALTHAM, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 11:15 a.m. PT. The live conference webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for approximately 90 days following the event. About ApellisApellis Phar",
    "url": "https://finance.yahoo.com/news/apellis-pharmaceuticals-present-44th-annual-120000115.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "32b1aff7-9000-3e5b-b957-874deda846f5",
      "content": {
        "id": "32b1aff7-9000-3e5b-b957-874deda846f5",
        "contentType": "STORY",
        "title": "Apellis Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "WALTHAM, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 11:15 a.m. PT. The live conference webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for approximately 90 days following the event. About ApellisApellis Phar",
        "pubDate": "2026-01-05T12:00:00Z",
        "displayTime": "2026-01-05T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/ee6969fd8bbd71bc3d94e172ead4fbb7",
          "originalWidth": 168,
          "originalHeight": 54,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qrYSg1FLDV8DmnC8biLcAA--~B/aD01NDt3PTE2ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/ee6969fd8bbd71bc3d94e172ead4fbb7.cf.webp",
              "width": 168,
              "height": 54,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/b0qEEczDh7piNZAmAaY07g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/ee6969fd8bbd71bc3d94e172ead4fbb7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/apellis-pharmaceuticals-present-44th-annual-120000115.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/apellis-pharmaceuticals-present-44th-annual-120000115.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "APLS"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T11:45:00+00:00",
    "headline": "Merck to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "RAHWAY, N.J., January 05, 2026--Merck to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
    "url": "https://finance.yahoo.com/news/merck-participate-44th-annual-j-114500100.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "7621566a-33eb-3319-a239-8a9a16bf684a",
      "content": {
        "id": "7621566a-33eb-3319-a239-8a9a16bf684a",
        "contentType": "STORY",
        "title": "Merck to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "RAHWAY, N.J., January 05, 2026--Merck to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
        "pubDate": "2026-01-05T11:45:00Z",
        "displayTime": "2026-01-05T11:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/c72212aa8717ebe3bb2e28818a03f56c",
          "originalWidth": 480,
          "originalHeight": 217,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/x96Nyp2qe9oU481JjIfb6A--~B/aD0yMTc7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/c72212aa8717ebe3bb2e28818a03f56c.cf.webp",
              "width": 480,
              "height": 217,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ADMXnlPGgeHDoYTKBWfmFg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/c72212aa8717ebe3bb2e28818a03f56c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-participate-44th-annual-j-114500100.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-participate-44th-annual-j-114500100.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T13:30:00+00:00",
    "headline": "CRISPR Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "ZUG, Switzerland and BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 8:15 a.m. PT in San Francisco. A live webcast of the presentation will be available on the \"Events & Presentations\" page in the Investors s",
    "url": "https://finance.yahoo.com/news/crispr-therapeutics-present-44th-annual-133000472.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "de90d713-5a93-3b85-8fe0-c0aa10b17a5a",
      "content": {
        "id": "de90d713-5a93-3b85-8fe0-c0aa10b17a5a",
        "contentType": "STORY",
        "title": "CRISPR Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "ZUG, Switzerland and BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 8:15 a.m. PT in San Francisco. A live webcast of the presentation will be available on the \"Events & Presentations\" page in the Investors s",
        "pubDate": "2026-01-05T13:30:00Z",
        "displayTime": "2026-01-05T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/1aff8de1b43a5c2c983997aa98d58aad",
          "originalWidth": 1800,
          "originalHeight": 1957,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mnPsJEczvucHirpNfZ3Hpg--~B/aD0xOTU3O3c9MTgwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/1aff8de1b43a5c2c983997aa98d58aad.cf.webp",
              "width": 1800,
              "height": 1957,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8jC0wMX28ixyv6Mj1oYr_A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/1aff8de1b43a5c2c983997aa98d58aad.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/crispr-therapeutics-present-44th-annual-133000472.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/crispr-therapeutics-present-44th-annual-133000472.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRSP"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T13:30:00+00:00",
    "headline": "Sarepta Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "CAMBRIDGE, Mass., January 05, 2026--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, Calif. on Monday, Jan. 12, 2026 at 12:00 p.m. E.T. / 9:00 a.m. P.T. Following the presentation there will be a Q&A session starting at 12:20 p.m. E.T. / 9:20 a.m. P.T.",
    "url": "https://finance.yahoo.com/news/sarepta-therapeutics-present-44th-annual-133000463.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "ceccc377-b9ca-3133-9b65-dd5467bfdbf6",
      "content": {
        "id": "ceccc377-b9ca-3133-9b65-dd5467bfdbf6",
        "contentType": "STORY",
        "title": "Sarepta Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "CAMBRIDGE, Mass., January 05, 2026--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, Calif. on Monday, Jan. 12, 2026 at 12:00 p.m. E.T. / 9:00 a.m. P.T. Following the presentation there will be a Q&A session starting at 12:20 p.m. E.T. / 9:20 a.m. P.T.",
        "pubDate": "2026-01-05T13:30:00Z",
        "displayTime": "2026-01-05T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/e1edd0e65e0f69dc9b4bf9425eb84b21",
          "originalWidth": 480,
          "originalHeight": 426,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PuOeeZcQLMcnTAvV5PsDQw--~B/aD00MjY7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/e1edd0e65e0f69dc9b4bf9425eb84b21.cf.webp",
              "width": 480,
              "height": 426,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4WZ6g5VzbtTcG7zWpnbJmQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/e1edd0e65e0f69dc9b4bf9425eb84b21.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sarepta-therapeutics-present-44th-annual-133000463.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sarepta-therapeutics-present-44th-annual-133000463.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SRPT"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T13:00:00+00:00",
    "headline": "Esperion to Participate in Upcoming 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "ANN ARBOR, Mich., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will present at J.P. Morgan’s 44th Annual Healthcare Conference on Wednesday, January 14, 2025. The company’s presentation and participation in a fireside chat will begin at 2:15 p.m. PT/5:15 p.m. ET. The live webcast can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after the completion of the",
    "url": "https://finance.yahoo.com/news/esperion-participate-upcoming-44th-annual-130000340.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "4d407cce-2077-39e8-9e07-b3b586b49b94",
      "content": {
        "id": "4d407cce-2077-39e8-9e07-b3b586b49b94",
        "contentType": "STORY",
        "title": "Esperion to Participate in Upcoming 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "ANN ARBOR, Mich., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will present at J.P. Morgan’s 44th Annual Healthcare Conference on Wednesday, January 14, 2025. The company’s presentation and participation in a fireside chat will begin at 2:15 p.m. PT/5:15 p.m. ET. The live webcast can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after the completion of the",
        "pubDate": "2026-01-05T13:00:00Z",
        "displayTime": "2026-01-05T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/d6b6d330931a2c020c55a96ce82ba685",
          "originalWidth": 3616,
          "originalHeight": 1136,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0zBHfJXtuehM7ErWQJKHfA--~B/aD0xMTM2O3c9MzYxNjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/d6b6d330931a2c020c55a96ce82ba685.cf.webp",
              "width": 3616,
              "height": 1136,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.Rq56rTzrXGmVnpKKmHwvw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d6b6d330931a2c020c55a96ce82ba685.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/esperion-participate-upcoming-44th-annual-130000340.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/esperion-participate-upcoming-44th-annual-130000340.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ESPR"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T13:00:00+00:00",
    "headline": "Scholar Rock to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "CAMBRIDGE, Mass., January 05, 2026--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to dramatically improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and debilitating neuromuscular diseases by applying its leading platform in myostatin biology to advance musculoskeletal health, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12 at 7:30 a.m. PST (",
    "url": "https://finance.yahoo.com/news/scholar-rock-present-44th-annual-130000669.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "1d86cfb6-17f0-3f7e-9923-a3d9b51e2040",
      "content": {
        "id": "1d86cfb6-17f0-3f7e-9923-a3d9b51e2040",
        "contentType": "STORY",
        "title": "Scholar Rock to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "CAMBRIDGE, Mass., January 05, 2026--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to dramatically improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and debilitating neuromuscular diseases by applying its leading platform in myostatin biology to advance musculoskeletal health, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12 at 7:30 a.m. PST (",
        "pubDate": "2026-01-05T13:00:00Z",
        "displayTime": "2026-01-05T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/3d04c890903e03d182e32c379d6276b3",
          "originalWidth": 480,
          "originalHeight": 200,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WulADIBFavOoXnSv.kc36g--~B/aD0yMDA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/3d04c890903e03d182e32c379d6276b3.cf.webp",
              "width": 480,
              "height": 200,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UcE7MFSNYkRW1o6rQc6MkA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/3d04c890903e03d182e32c379d6276b3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/scholar-rock-present-44th-annual-130000669.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/scholar-rock-present-44th-annual-130000669.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SRRK"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T13:00:00+00:00",
    "headline": "BlossomHill Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12",
    "summary": "SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company focused on the design and development of next-generation medicines for cancer, today announced the company will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 2:00 p.m. PT. J. Jean Cui, Ph.D., President & Chief Executive Officer, and Geoff Oxnard, M.D., Chief Medical Officer, will provide an overview of the company’s",
    "url": "https://finance.yahoo.com/news/blossomhill-therapeutics-present-44th-annual-130000431.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "d0caac95-fb4e-307d-9c7c-53d18310be64",
      "content": {
        "id": "d0caac95-fb4e-307d-9c7c-53d18310be64",
        "contentType": "STORY",
        "title": "BlossomHill Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12",
        "description": "",
        "summary": "SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company focused on the design and development of next-generation medicines for cancer, today announced the company will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 2:00 p.m. PT. J. Jean Cui, Ph.D., President & Chief Executive Officer, and Geoff Oxnard, M.D., Chief Medical Officer, will provide an overview of the company’s",
        "pubDate": "2026-01-05T13:00:00Z",
        "displayTime": "2026-01-05T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/a871048b5f17669484923fa18fb0c973",
          "originalWidth": 2659,
          "originalHeight": 1303,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_RiCQ8PMs38Fz85BG9bG7w--~B/aD0xMzAzO3c9MjY1OTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/a871048b5f17669484923fa18fb0c973.cf.webp",
              "width": 2659,
              "height": 1303,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xSKZPEjk0VsS3tt4xeW1rw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/a871048b5f17669484923fa18fb0c973.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/blossomhill-therapeutics-present-44th-annual-130000431.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/blossomhill-therapeutics-present-44th-annual-130000431.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T13:00:00+00:00",
    "headline": "Circle Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "SOUTH SAN FRANCISCO, Calif., January 05, 2026--Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, today announced that David J. Earp, J.D., Ph.D., president and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 5:00 p.m. PT.",
    "url": "https://finance.yahoo.com/news/circle-pharma-present-44th-annual-130000750.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "3871b7d5-8e28-3565-9650-0a5833334338",
      "content": {
        "id": "3871b7d5-8e28-3565-9650-0a5833334338",
        "contentType": "STORY",
        "title": "Circle Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "SOUTH SAN FRANCISCO, Calif., January 05, 2026--Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, today announced that David J. Earp, J.D., Ph.D., president and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 5:00 p.m. PT.",
        "pubDate": "2026-01-05T13:00:00Z",
        "displayTime": "2026-01-05T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/0589b5e73c995d4626ea34722c06eaea",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/S_5_.WZgEF3aDgp3RBzaZg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/0589b5e73c995d4626ea34722c06eaea.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l8mQRc7ZWXbhPY9IIPg7FA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/0589b5e73c995d4626ea34722c06eaea.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/circle-pharma-present-44th-annual-130000750.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/circle-pharma-present-44th-annual-130000750.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T13:00:00+00:00",
    "headline": "Star Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12",
    "summary": "SOUTH SAN FRANCISCO, Calif., January 05, 2026--Star Therapeutics, a late clinical-stage biotechnology company discovering and developing best-in-class antibodies for bleeding disorders and other diseases, today announced that Adam Rosenthal, Ph.D., CEO and Founder, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 4:30 p.m. PT in San Francisco, CA.",
    "url": "https://finance.yahoo.com/news/star-therapeutics-present-44th-annual-130000619.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "f06282bb-cb2d-3077-836f-d0e00f5119a3",
      "content": {
        "id": "f06282bb-cb2d-3077-836f-d0e00f5119a3",
        "contentType": "STORY",
        "title": "Star Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12",
        "description": "",
        "summary": "SOUTH SAN FRANCISCO, Calif., January 05, 2026--Star Therapeutics, a late clinical-stage biotechnology company discovering and developing best-in-class antibodies for bleeding disorders and other diseases, today announced that Adam Rosenthal, Ph.D., CEO and Founder, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 4:30 p.m. PT in San Francisco, CA.",
        "pubDate": "2026-01-05T13:00:00Z",
        "displayTime": "2026-01-05T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/2c0ba08f362de6c35401a735475fe19f",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6WAOkxVPG3yow.i28Zybfw--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/2c0ba08f362de6c35401a735475fe19f.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/b6mP7Y_XGPo0smf3qBBJYA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/2c0ba08f362de6c35401a735475fe19f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/star-therapeutics-present-44th-annual-130000619.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/star-therapeutics-present-44th-annual-130000619.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T14:15:00+00:00",
    "headline": "Alnylam to Webcast Presentation at 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "CAMBRIDGE, Mass., January 05, 2026--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview and participate in a Q&A session at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 9:00 am PT (12:00 pm ET) at The Westin St. Francis in San Francisco. During the presentation, the Company will unveil its new five-year strategy, which will guide the Company’s next phase of growth.",
    "url": "https://finance.yahoo.com/news/alnylam-webcast-presentation-44th-annual-141500992.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "d4885f4e-d055-3bcc-9fc9-8b15645b38f3",
      "content": {
        "id": "d4885f4e-d055-3bcc-9fc9-8b15645b38f3",
        "contentType": "STORY",
        "title": "Alnylam to Webcast Presentation at 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "CAMBRIDGE, Mass., January 05, 2026--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview and participate in a Q&A session at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 9:00 am PT (12:00 pm ET) at The Westin St. Francis in San Francisco. During the presentation, the Company will unveil its new five-year strategy, which will guide the Company’s next phase of growth.",
        "pubDate": "2026-01-05T14:15:00Z",
        "displayTime": "2026-01-05T14:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/3b986962bba2faeb9ab5e1d348fc8b19",
          "originalWidth": 1552,
          "originalHeight": 440,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DgsfL5HoD7T4sM2Vwq406A--~B/aD00NDA7dz0xNTUyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/3b986962bba2faeb9ab5e1d348fc8b19.cf.webp",
              "width": 1552,
              "height": 440,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Os4QmeWb_crvfD3rDH365g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/3b986962bba2faeb9ab5e1d348fc8b19.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/alnylam-webcast-presentation-44th-annual-141500992.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/alnylam-webcast-presentation-44th-annual-141500992.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ALNY"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T04:34:02+00:00",
    "headline": "2 Dow Jones Stocks to Research Further and 1 We Find Risky",
    "summary": "The Dow Jones (^DJI) is home to corporate giants, but size alone doesn’t guarantee success. A few of these companies are struggling with weak fundamentals, paradigm shifts, or poor execution.",
    "url": "https://finance.yahoo.com/news/2-dow-jones-stocks-research-043402068.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "504cd9aa-81b2-3af8-9499-326ab01f06e2",
      "content": {
        "id": "504cd9aa-81b2-3af8-9499-326ab01f06e2",
        "contentType": "STORY",
        "title": "2 Dow Jones Stocks to Research Further and 1 We Find Risky",
        "description": "",
        "summary": "The Dow Jones (^DJI) is home to corporate giants, but size alone doesn’t guarantee success. A few of these companies are struggling with weak fundamentals, paradigm shifts, or poor execution.",
        "pubDate": "2026-01-05T04:34:02Z",
        "displayTime": "2026-01-05T04:34:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/f51f4d4c5661c6fe3b49ec2d77462a15",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "AMZN Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4lDOWNFN9.GIx0Hhkt0GZw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/f51f4d4c5661c6fe3b49ec2d77462a15.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ozmJu146T70Y1C6s_aKNzg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/f51f4d4c5661c6fe3b49ec2d77462a15.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/2-dow-jones-stocks-research-043402068.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-dow-jones-stocks-research-043402068.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "AXP"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "^DJI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]